TRIDENT LIFELINE
|
TRIDENT LIFELINE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Profit Before Tax | ₹8.70 Cr | ₹6.58 Cr | ₹2.98 Cr |
Adjustment | ₹0.12 Cr | ₹0.08 Cr | ₹0.33 Cr |
Changes In working Capital | ₹-4.20 Cr | ₹-25 Cr | ₹-3.67 Cr |
Cash Flow after changes in Working Capital | ₹4.61 Cr | ₹-18 Cr | ₹-0.36 Cr |
Cash Flow from Operating Activities | ₹2.23 Cr | ₹-19 Cr | ₹-0.21 Cr |
Cash Flow from Investing Activities | ₹-20 Cr | ₹-9.69 Cr | ₹-0.45 Cr |
Cash Flow from Financing Activities | ₹11 Cr | ₹42 Cr | ₹0.80 Cr |
Net Cash Inflow / Outflow | ₹-7.13 Cr | ₹14 Cr | ₹0.14 Cr |
Opening Cash & Cash Equivalents | ₹14 Cr | ₹0.18 Cr | ₹0.01 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - |
Closing Cash & Cash Equivalent | ₹6.65 Cr | ₹14 Cr | ₹0.16 Cr |
Compare Cashflow Statement of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹318.5 Cr | 0.7% | -0.2% | 77.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 0.7% |
-0.2% |
77.5% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses